A survey on hematology-oncology pediatric AIEOP centers: Prophylaxis, empirical therapy and nursing prevention procedures of infectious complications

Haematologica

Volumn 97, Issue 1, 2012, Pages 147-150

  Livadiotti, Susanna ^a   Milano, Giuseppe Maria ^b   Serra, Annalisa ^a   Folgori, Laura ^a   Jenkner, Alessandro ^a   Castagnola, Elio ^c   Cesaro, Simone ^d   Rossi, Mario R ^e   Barone, Angelica ^f   Zanazzo, Giulio ^g   Nesi, Francesca ^h   Licciardello, Maria ⁱ   De Santis, Raffaella ^j   Ziino, Ottavio ^k   Cellini, Monica ^l   Porta, Fulvio ^m   Caselli, Desiree ⁿ   Pontrelli, Giuseppe ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d Pediatric Hematology Oncology   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL OF PARMA   (Italy)

^g INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^h REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

ⁱ Policlinico Gaspare Rodolico   (Italy)

^j Pediatric Hematology Oncology   (Italy)

^k Ospedale dei Bambini G Di Cristina   (Italy)

^l UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^m Ospedale dei Bambini   (Italy)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

Empirical therapy; Infectious diseases; Neutropenia fever; Pedi atric; Prophylaxis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL PRACTICE; DRUG SUBSTITUTION; EMPIRICAL THERAPY; FEBRILE NEUTROPENIA; FEMALE; GRAFT RECIPIENT; HEMATOLOGY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFECTIOUS COMPLICATION; ITALY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NURSING; ONCOLOGY; PNEUMOCYSTOSIS; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; VIRUS INFECTION;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; QUESTIONNAIRES;

EID: 84855209420     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.048918     Document Type: Article

References (22)

1. Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol. 1999; 21(6):501-8.
2. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296-304.
3. Ziglam HM, Gelly KJ, Olver WJ. A survey of the antibiotic treatment of febrile neutrope-nia in haematology units in the United Kingdom. Clin Lab Haematol. 2005;27(6): 374-8.
4. Ziglam HM, Gelly KJ, Olver WJ. A survey of the management of neutropenic fever in oncology units in the UK. Int J of Antimicrob Agents. 2007;29(4):430-3.
5. Choi SM, Park SH, Lee DG, Choi JH, Yoo JH, Shin WS. Current Antimicrobial Usage for the Management of Neutropenic Fever in Korea: A Nationwide Survey. J Korean Med Sci. 2008;23(6):941-7.
6. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 2005;142(12 Pt 1):979-95. Erratum in: Ann Intern Med. 2006;144(9): 704.
7. Leibovici L, Paul M, Cullen M, Bucaneve G, Gafter-Gvili A, Fraser A, et al. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. Cancer. 2006;107 (8):1743-51.
8. Yousef AA, Fryer CJ, Chedid FD, Abbas AA, Felimban SK, Khattab TM. A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lym-phoblastic leukemia. Pediatr Blood Cancer. 2004;43(6):637-43.
9. Castagnola E, Boni L, Giacchino M, Cesaro S, De Sio L, Garaventa A, et al. Infectious Diseases Study Group of the Italian Association of Pediatric Hematology and Oncology. A multicenter, randomized, double blind placebo-controlled trial of amoxi-cillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J. 2003;22(4):359-65.
10. Maertens J. Evaluating prophylaxis of invasive fungal infections in patients with haematological malignancies. Eur J Haematol. 2007;78(4):275-82.
11. Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, et al. Third European Conference on Infections in Leukemia European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update. Bone Marrow Transplant. 2011;46(5):709-18.
12. Styczynski J, Reusser P, Einsele H, de la Camara R, Cordonnier C, Ward KN, et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant. 2009;43(10):757-70.
13. Paul M, Soares-Weiser K, Grozinsky S, Leibovici L. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev. 2003;(3):CD003038.
14. Paul M, Yahav D, Fraser A, Leibovici LJ. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Antimicrob Chemother. 2006;57(2):176-89.
15. Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison. J Microbiol Immununol Infec. 2009;42(2):141-7.
16. Santolaya ME. Supportive care in children Current Opinion in Oncology. 2010;22(4): 323-9.
17. Paul M, Borok S, Fraser A, Vidal L, Cohen M, Leibovici L. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database Syst Rev. 2005;(3):CD003914.
18. Paul M, Borok S, Fraser A, Vidal L, Leibovici L. Empirical antibiotics against Gram positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2005;55(4):436-44.
19. Pizzo P. Where do we go from here? USA J Antimicrob Chemother. 2009;63 (Suppl 1):i 16-17.
20. Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, et al. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Caspofungin Pediatric Study Group. Pediatr Infect Dis J. 2010;29 (5):415-20.
21. Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Royal Free Hospital and School of Medicine, London. Br J Haematol. 1997;98 (3):711-8.
22. Viscoli C, Castagnola E. Prophylaxis and Empirical Therapy of Infection in Cancer Patients. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, Churchill Livingstone Elsevier, 2010; p:3793-807.